NCT02830282View on ClinicalTrials.gov

Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 16, 2018

Study Completion Date

March 16, 2018

Conditions
Breast Cancer
Interventions
OTHER

Blood Collection

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02830282 - Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter